Summary of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2023

Accounting Policies [Abstract]

Schedule of Accounts Payable and Accrued Liabilities

Accounts Payable and Accrued Liabilities

(in thousands)	March 31, 2023		December 31, 2022
Accounts payable	$	3,908	$	4,637
Accrued non-clinical liabilities	26,325		22,535
Accrued clinical liabilities	3,657		5,400
Total accounts payable and accrued liabilities	$	33,890	$	32,572

Schedule of Potentially Dilutive Securities not Included in Calculation of Diluted Net Loss Per Share

Common stock equivalent securities not included in the calculation of diluted net loss per share, because to do so would be anti-dilutive, are as follows (in common stock equivalent shares; in thousands):

	March 31,
	2023	2022
Common stock options	10,973	8,284
Restricted stock units	607	—
ESPP shares pending issuance	44	23
Total	11,624	8,307